Literature DB >> 24220341

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.

Yanfei Ma1, Huadong Qin, Yunfu Cui.   

Abstract

MicroRNAs (miRNAs) are fundamental regulators of cell proliferation, differentiation, and apoptosis, and are implicated in tumorigenesis of many cancers. MiR-34a is best known as a tumor suppressor through repression of growth factors and oncogenes. Growth arrest specific1 (GAS1) protein is a tumor suppressor that inhibits cancer cell proliferation and induces apoptosis through inhibition of RET receptor tyrosine kinase. Both miR-34a and GAS1 are frequently down-regulated in various tumors. However, it has been reported that while GAS1 is down-regulated in papillary thyroid carcinoma (PTC), miR-34a is up-regulated in this specific type of cancer, although their potential roles in PTC tumorigenesis have not been examined to date. A computational search revealed that miR-34a putatively binds to the 3'-UTR of GAS1 gene. In the present study, we confirmed previous findings that miR-34a is up-regulated and GAS1 down-regulated in PTC tissues. Further studies indicated that GAS1 is directly targeted by miR-34a. Overexpression of miR-34a promoted PTC cell proliferation and colony formation and inhibited apoptosis, whereas knockdown of miR-34a showed the opposite effects. Silencing of GAS1 had similar growth-promoting effects as overexpression of miR-34a. Furthermore, miR-34a overexpression led to activation of PI3K/Akt/Bad signaling pathway in PTC cells, and depletion of Akt reversed the pro-growth, anti-apoptotic effects of miR-34a. Taken together, our results demonstrate that miR-34a regulates GAS1 expression to promote proliferation and suppress apoptosis in PTC cells via PI3K/Akt/Bad pathway. MiR-34a functions as an oncogene in PTC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GAS1; GDNF; GPI; MiR-34a; PI3K/Akt/Bad pathway; PTC; Papillary thyroid carcinoma; UTR; glial cell-derived neurotrophic factor; glycosylphosphatidylinositol; growth arrest specific1; miR-34a; microRNA-34a; papillary thyroid carcinoma; untranslated region

Mesh:

Substances:

Year:  2013        PMID: 24220341     DOI: 10.1016/j.bbrc.2013.11.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  50 in total

1.  Doxorubicin resistance mediated by cytoplasmic macrophage colony-stimulating factor is associated with switch from apoptosis to autophagic cell death in MCF-7 breast cancer cells.

Authors:  Mengxia Zhang; Hailiang Zhang; Fan Tang; Yuhua Wang; Zhongcheng Mo; Xiaoyong Lei; Shengsong Tang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-24

2.  MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors.

Authors:  Veronika Mancikova; Esmeralda Castelblanco; Elena Pineiro-Yanez; Javier Perales-Paton; Aguirre A de Cubas; Lucia Inglada-Perez; Xavier Matias-Guiu; Ismael Capel; Maria Bella; Enrique Lerma; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Francisco Maravall; Didac Mauricio; Fatima Al-Shahrour; Mercedes Robledo
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

Review 3.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma.

Authors:  Zhijun Zhao; Fei Yang; Yan Liu; Kai Fu; Shanghua Jing
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

5.  MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells.

Authors:  Rui Zhang; Hui Luo; Shuai Wang; Zhengxin Chen; Lingyang Hua; Hong-Wei Wang; Wanghao Chen; Yongsheng Yuan; Xiaobin Zhou; Daqian Li; Shuying Shen; Tao Jiang; Yongping You; Ning Liu; Huibo Wang
Journal:  J Neurooncol       Date:  2014-09-26       Impact factor: 4.130

6.  miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.

Authors:  Rui Li; Jia Liu; Qun Li; Guang Chen; Xiaofang Yu
Journal:  Tumour Biol       Date:  2015-10-19

7.  Edaravone ameliorates experimental autoimmune thyroiditis in rats through HO-1-dependent STAT3/PI3K/Akt pathway.

Authors:  Hong Li; Jie Min; Xiaoming Mao; Xueyang Wang; Yucheng Yang; Yuting Chen
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

8.  Altered expression of apoptosis-regulating miRNAs in salivary gland tumors suggests their involvement in salivary gland tumorigenesis.

Authors:  Bianca de Cássia Troncarelli de Campos Parra Flores; Silvia Vanessa Lourenço; Aline Santos Damascena; Luiz Paulo Kowaslki; Fernando Augusto Soares; Cláudia Malheiros Coutinho-Camillo
Journal:  Virchows Arch       Date:  2016-12-15       Impact factor: 4.064

Review 9.  Serum miRNAs as Biomarkers for the Diagnosis and Prognosis of Thyroid Cancer: A Comprehensive Review of the Literature.

Authors:  Mohammad-Reza Mahmoudian-Sani; Ameneh Mehri-Ghahfarrokhi; Majid Asadi-Samani; Gholam-Reza Mobini
Journal:  Eur Thyroid J       Date:  2017-04-07

10.  Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.

Authors:  Weiwei Liang; Zhiwei Xie; Weiling Cui; Yan Guo; Lijuan Xu; Jueheng Wu; Hongyu Guan
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-10       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.